Transforming growth factors-β1 and β2 in serum and urine from patients with bladder carcinoma

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 953-957

  Eder, Iris E ^a   Stenzl, Arnulf ^a   Hobisch, Alfred ^a   Cronauer, Marcus V ^a   Bartsch, Georg ^a   Klocker, Helmut ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

bladder neoplasms; lymph nodes; neoplasm metastasis; transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERUM; URINALYSIS;

EID: 0029764375     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65670-2     Document Type: Article

References (46)

1. Gordon, J. N., Shu, W. P., Schlussel, R. N., Droller, M. J. and Liu, B. C.: Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells. Cancer Res., 53: 4971, 1993.
2. Mydlo, J. H. and Macchia, R. J.: Growth factors in urologic tissues: detection, characterization, and clinical applications. Urology, 40: 491, 1992.
3. Bouck, N.: Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells, 2: 179, 1990.
4. Folkman, J., Watson, K., Ingber, D. and Hanahan, D.: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339: 58, 1989.
5. Weidner, N., Semple, J. P., Welch, W. R. and Folkman, J.: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New Engl. J. Med., 324: 1, 1991.
6. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. G.: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327, 1991.
7. Massagué, J.: The transforming growth factor-beta family. Ann. Rev. Cell. Biol., 6: 597, 1990.
8. Barnard, J. A., Lyons, R. M. and Moses, H. L.: The cell biology of transforming growth factor beta. Biochim. Biophys. Acta, 1032: 79, 1990.
9. Yang, E. Y. and Moses, H. L.: Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell. Biol., 111: 731, 1990.
10. Kehrl, J. H.: Transforming growth factor-beta: an important mediator of immunoregulation. Int. J. Cell Cloning, 9: 438, 1991
11. Roberts, A. B., Lamb, L. C., Newton, D. L., Sporn, M. B., De Larco, J. E. and Todaro, G. J.: Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci., 77: 3494, 1980.
12. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V. and Kehrl, J. H.: Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci., 83: 4167, 1986.
13. Welch, D. R., Fabra, A. and Nakajima, M.: Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci., 87: 7678, 1990.
14. Wilding, G.: Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta. Cancer Surv., 11: 147, 1991.
15. Tucker, R. F., Shipley, G. D., Moses, H. L. and Holley, R. W.: Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science, 226: 705, 1984.
16. Moses, H. L., Tucker, R. F., Leof, E. B., Coffey, R. J., Jr., Halper, J. and Shipley, G. D.: Type β transforming growth factor is a growth stimulator and a growth inhibitor. In: Growth Factors and Transformation. Edited by J. Feramisco, B. Ozanne and C. Stiles. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, pp. 65-71, 1985.
17. Hubbs, A. F., Hahn, F. F. and Thomassen, D. G.: Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells. Carcinogenesis, 10: 1599, 1989.
18. Wakefield, L. M., Colletta, A. A., McCune, B. K. and Sporn, M. B.: Roles for transforming growth factor-β in the genesis, prevention, and treatment of breast cancer. Cancer Treat. Res., 61: 97, 1992.
19. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. and Sporn, M. B.: Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem., 258: 7155, 1983.
20. Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R. and Dickson, R. B.: Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417, 1987.
21. Liu, C., Tsao, M. S. and Grisham, J. W.: Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Cancer Res, 48: 850, 1988.
22. Jennings, M. T., Maciunas, R. J., Carver, R., Bascom, C. C., Juneau, P., Misulis, K. and Moses, H. L.: TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int. J. Cancer, 49: 129, 1991.
23. Pircher, R., Jullien, P. and Lawrence, D. A.: Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun., 136: 30, 1986.
24. Lyons, R. M., Gentry, L. E., Purchio, A. F. and Moses, H. L.: Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell. Biol., 110:1361, 1990.
25. Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C. Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M. and Chauhan, A.: The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nature Med., 1: 74, 1995.
26. Sporn, M. B., Roberts, A. B., Wakefield, L. M. and de Crombrugghe, B.: Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell. Biol., 105: 1039, 1987.
27. Roberts, A. B. and Sporn, M. B.: The transforming growth factor-βs. In: Handbook of Experimental Pharmacology, 95th ed. New York: Springer Verlag, pp. 419-472, 1990.
28. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B. and Sporn, M. B.: Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J. Cell Physiol., 138 79, 1989.
29. Danielpour, D.: Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J. Immunol. Methods, 158: 17, 1993.
30. Shahabuddin, S., Arnold, F., Costello, C. B. and Kumar, S.: Tumor angiogenesis factor in urological cancers. Brit. J. Urol., 56: 490, 1984.
31. Stenzl, A. and deKernion, J. B.: Current trends in diagnosis and treatment of renal, upper urinary tract, and bladder carcinomas. In: Endocrine Dependent Tumors. Edited by K. D. Voight and K. Knabbe. New York: Raven Press, 1991.
32. Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M. and Geliebter, J.: Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer. Nature Med., 1: 282, 1995.
33. Kong, F. M., Anscher, M. S., Murase, T., Abbott, B. D., Iglehart, J. D. and Jirtle, R. L.: Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann. Surg., 222: 155, 1995.
34. Shirai, Y., Kawata, S., Tamura, S., Ito, N., Tsushima, H., Takaishi, K., Kiso, S. and Matsuzawa, Y.: Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer, 73: 2275, 1994.
35. Lutzeyer, W., Rübben, H. and Dahm, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127: 250, 1982.
36. Torti, F. M., Lum, B. L., Aston, D., MacKenzie, N., Faysel, M., Shortliffe, L. D. and Freiha, F.: Superficial bladder cancer: the primacy of grade in the development of invasive disease. J. Clin. Oncol., 5: 125, 1987.
37. Wakefield, L. M., Letterio, J. J., Chen, T., Danielpour, D., Allison, R. S. H., Pai, L. H., Denicoff, A. M., Noone, M. H., Cowan, K. H., O'Shoughnessy, A. and Sporn, M. B.: Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin. Cancer Res., 1: 129, 1995.
38. Thomspon, T. C., Truong, L. D., Timme, T. L., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T. and Park, S. H.: Transforming growth factor beta 1 as a biomarker for prostate cancer. J. Cell. Biochem., suppl., 16H: 54, 1992.
39. Steiner, M., Zhou, Z. Z., Tonb, D. C. and Barrack, E. R.: Expression of transforming growth factor-β1 in prostate cancer. Endocrinology, 135: 2240, 1994.
40. Coombs, L. M., Pigott, D. A., Eydmann, M. E., Proctor, A. J. and Knowles, M. A.: Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma. Brit. J. Cancer, 67: 578, 1993.
41. Kopp, A., Jonat, W., Schmahl, M. and Knabbe, C.: Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res., 55: 4512, 1995.
42. Chodak, G. W., Hospelhorn, V., Judge, S. M., Mayforth, R., Koeppen, H. and Sasse, J.: Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res., 48: 2083, 1988.
43. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P. and Folkman, J.: Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 85: 241, 1993.
44. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F. and Folkman, J.: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356, 1994.
45. Wakefield, L. M., Smith, D. M., Broz, S., Jackson, M., Levinson, A. D. and Sporn, M. B.: Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors, 1: 203, 1989.
46. O'Connor-McCourt, M. D. and Wakefield, L. M.: Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J. Biol. Chem., 262: 14090, 1987.